Matthew Callahan

Matthew Callahan

Company: Botanix

Job title: Founder and Board Director


Matt Callahan is the founder and board director of Botanix Pharmaceuticals Ltd.  Botanix is one of the world’s leading clinical cannabinoid companies with two skin disease programs that are preparing for Phase 3 studies and an antimicrobial platform that is entering Phase 2.  Matt is a founder of Orthocell Ltd, Emerald Clinics, Dimerix Bioscience and iCeutica Inc and has more than 25 years legal and investment experience across a range of biotech and pharmaceutical sectors


Cannabinoids as A New Class of Antimicrobials 2:15 pm

• Exploring how cannabinoids kill bacteria via newly identified mechanism • Myth busting: Are cannabinoids gram positive and gram negative acting? • Evaluating challenges of bioavailability and addressing difficulties with protein bindingRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.